Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Non-Current Assets: 2016-2025

Historic Non-Current Assets for Rhythm Pharmaceuticals (RYTM) over the last 8 years, with Sep 2025 value amounting to $12.1 million.

  • Rhythm Pharmaceuticals' Non-Current Assets fell 48.03% to $12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 million, marking a year-over-year decrease of 48.03%. This contributed to the annual value of $18.1 million for FY2024, which is 26.16% down from last year.
  • Latest data reveals that Rhythm Pharmaceuticals reported Non-Current Assets of $12.1 million as of Q3 2025, which was up 0.16% from $12.1 million recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Non-Current Assets registered a high of $31.4 million during Q1 2022, and its lowest value of $9.9 million during Q2 2021.
  • Its 3-year average for Non-Current Assets is $21.2 million, with a median of $23.2 million in 2024.
  • Per our database at Business Quant, Rhythm Pharmaceuticals' Non-Current Assets spiked by 262.88% in 2021 and then crashed by 50.76% in 2025.
  • Over the past 5 years, Rhythm Pharmaceuticals' Non-Current Assets (Quarterly) stood at $21.1 million in 2021, then spiked by 33.63% to $28.2 million in 2022, then dropped by 13.34% to $24.5 million in 2023, then dropped by 26.16% to $18.1 million in 2024, then plummeted by 48.03% to $12.1 million in 2025.
  • Its Non-Current Assets stands at $12.1 million for Q3 2025, versus $12.1 million for Q2 2025 and $17.4 million for Q1 2025.